A textile entrepreneur in Bangladesh's Gazipur district who watched the news in September 2024 saw the interim government announce a New Industrial Policy 2024 — promising economic zones with fast-track FDI, tax holidays for priority sectors, and a specific commitment to diversify beyond RMG into pharmaceuticals, light engineering, and ICT (Government of Bangladesh, September 2024). That policy announcement is the clearest signal that business opportunities in Bangladesh are no longer confined to the garment sector.
Bangladesh produced USD 47 billion in RMG exports in FY2024, making it the world's second-largest garment exporter after China (Export Promotion Bureau, Bangladesh, 2024). But the garment sector itself is evolving — moving from basic cut-make-trim operations toward design, sourcing, and man-made fibre production. And beyond garments, Bangladesh's pharmaceutical sector — which now exports to over 150 countries — and its rising light engineering cluster are building an industrial base far more diversified than headlines suggest.
|
At a Glance: Starting a Business in Bangladesh
GDP Growth: ~5.8% in FY2024; projected 6.5–7% as political transition stabilises (IMF, 2024)
Population: ~170 million; fastest-growing middle class in South Asia
Key Sectors: Readymade garments (RMG), pharmaceuticals, light engineering, agro-processing, leather
RMG Share of Exports: ~84% of total national exports (~USD 47 billion in FY2024)
Investment Zones: 8 EPZs (Export Processing Zones) + 100 Economic Zones (BEZA)
Key Licence Required: Trade Licence from Local Authority; IRC/ERC from BIDA for imports/exports
|
Four Sectors Where Bangladesh Offers Clear Business Entry Points
The readymade garments (RMG) sector remains the anchor, but the opportunity for new entrants is in the upstream supply chain: yarns, fabrics, dyes, packaging, and accessories. Bangladesh currently imports approximately USD 5 billion in fabric and textiles annually — primarily from China and India. A yarn spinning or fabric weaving unit serving the domestic RMG sector has a captive market of 4,500+ garment factories and no requirement to build its own export logistics.
|
The Fabric Import Gap: Bangladesh's Biggest Internal Opportunity
Bangladesh's garment factories import USD 5+ billion in fabrics annually despite being the world's second-largest garment exporter. A fabric mill or yarn spinning unit in Gazipur or Narayanganj is supplying into a captive domestic demand pool of 4,500+ factories with zero export complexity. (Export Promotion Bureau Bangladesh, 2024)
|
Pharmaceuticals are Bangladesh's most structurally protected export sector. As a Least Developed Country (LDC), Bangladesh is exempt from TRIPS patent obligations until 2033 — meaning domestic pharma companies can legally manufacture patented molecules that would be restricted anywhere else in the world. The country has over 250 licensed pharmaceutical manufacturers and exports generic medicines to 150+ countries. A pharmaceutical manufacturing investment in Bangladesh — whether by an Indian company setting up a JV or a local entrepreneur entering contract manufacturing — benefits from a unique global regulatory window.
|
The TRIPS Exemption: A Competitive Moat That Expires in 2033
As an LDC, Bangladesh can legally manufacture patented pharmaceutical molecules without licence until 2033. This makes Bangladeshi generic manufacturers globally competitive in life-saving drugs — antiretrovirals, cancer generics, oncology APIs — that no other country can produce at similar scale without infringing patents. A pharma manufacturer entering Bangladesh today has an 8-year production window with no global competition. (WTO TRIPS Council; DGDA Bangladesh, 2024)
|
Light engineering — nuts, bolts, bicycle parts, auto components, electrical fittings — is the fourth-largest export category by volume and Bangladesh's fastest-growing industrial segment by unit count. Bogura and Dhaka's Hatirjheel cluster are established light engineering hubs with 10,000+ small units. An investor entering with quality management (ISO 9001), modern CNC equipment, and direct export linkages can capture significant premium over incumbent producers.
Agro-processing rounds out the opportunity set. Bangladesh's population of 170 million has one of South Asia's fastest-growing urban consumer bases. Demand for packaged rice, flour, vegetable oil, biscuits, and fruit juices is growing at 10–12% annually (FICCI-Bangladesh estimate, 2024). Import substitution of packaged consumer foods is a durable and growing opportunity.
Market Data & Growth Evidence
Bangladesh's GDP per capita has grown from USD 864 in 2015 to approximately USD 2,765 in 2024 — a tripling in less than a decade (World Bank, 2024). This income growth has created a domestic consumer market that barely existed 10 years ago. The pharmaceutical export market grew from USD 130 million in FY2019 to over USD 230 million in FY2024 — a 77% increase in 5 years (DGDA Bangladesh / EPB data).
|
Year
|
Bangladesh GDP (USD bn)
|
RMG Exports (USD bn)
|
Pharma Exports (USD mn)
|
Notes
|
|
FY2020
|
~331
|
~27.9
|
~130
|
COVID impact on RMG
|
|
FY2021
|
~355
|
~31.5
|
~150
|
Strong recovery
|
|
FY2022
|
~460
|
~42.6
|
~190
|
Record RMG year
|
|
FY2023
|
~460
|
~47.4
|
~215
|
Post-COVID demand surge
|
|
FY2024
|
~455 (est.)
|
~47.0
|
~230
|
Political transition; soft GDP
|
|
FY2027E
|
~540 (est.)
|
~58 (est.)
|
~350 (est.)
|
Industry estimate; 7% CAGR
|
|
FY2030E
|
~680 (est.)
|
~75 (est.)
|
~500 (est.)
|
Post-LDC graduation scenario
|
|
FY2035E
|
~950 (est.)
|
~100 (est.)
|
~800 (est.)
|
Author estimate; base FY2024
|
Sources: World Bank, Export Promotion Bureau Bangladesh (EPB), DGDA Bangladesh, IMF. Forecasts are author estimates; not official government projections.
What Official Data Tells Investors About Bangladesh's Industrial Base
The Bangladesh Export Processing Zones Authority (BEPZA) manages 8 EPZs that collectively house over 800 industrial enterprises, employ 450,000+ workers, and generate USD 6+ billion in annual export value (BEPZA Annual Report, 2023–24). The Bangladesh Economic Zones Authority (BEZA) has approved 100 economic zones across the country, with 30+ in active development — providing serviced industrial land at accessible terms for domestic and foreign investors.
The Bangladesh Investment Development Authority (BIDA) recorded over USD 4 billion in registered foreign investment in FY2023–24, with China, South Korea, India, and Japan as the top source countries. The FY2024 New Industrial Policy commits to reducing investment permit timelines from 45 days to 7 days through digital single-window clearance — a significant operational improvement for foreign investors.
|
Data Point
|
Statistic
|
Source & Year
|
|
RMG exports (FY2024)
|
USD ~47 billion
|
Export Promotion Bureau (EPB), 2024
|
|
Number of RMG factories (active)
|
~4,500+
|
BGMEA, 2024
|
|
EPZ enterprises (BEPZA managed)
|
800+ units
|
BEPZA Annual Report, 2023–24
|
|
EPZ employment
|
450,000+ workers
|
BEPZA Annual Report, 2023–24
|
|
Pharma export countries served
|
150+ countries
|
DGDA Bangladesh / EPB, 2024
|
|
BEZA-approved economic zones
|
100 zones (30+ active)
|
BEZA, 2024
|
|
FDI registered (FY2023–24)
|
USD 4+ billion
|
BIDA, 2024
|
Sources: Export Promotion Bureau (EPB), BGMEA, BEPZA, BEZA, BIDA, DGDA Bangladesh. 2024 data.
Investment Incentives and Government Support in Bangladesh
Bangladesh offers competitive investment incentives for foreign and local investors. EPZ benefits include: 10-year tax holiday for industries established in EPZs, duty-free import of capital machinery and raw materials, unrestricted profit and dividend repatriation, and exemption from double taxation (Bangladesh Investment Development Authority data).
The New Industrial Policy 2024 adds: priority sector designation for pharmaceuticals, light engineering, ICT, and agro-processing (with attendant tax holidays of 5–10 years); a digital single-window investment registration system targeting 7-day processing; and a dedicated Bangladesh Startup Accelerator Fund with BDT 500 crore initial corpus.
For the pharmaceutical sector, the Drug Administration of Bangladesh (DGDA) provides streamlined approval for facilities meeting WHO-GMP standards — a prerequisite for export to regulated markets including the EU and Canada. BIDA provides market linkage facilitation specifically for pharma exporters targeting new geographies.
Export Opportunities for Bangladesh-Based Manufacturers
Bangladesh's biggest export advantage is preferential access to global markets under its LDC status. The EU's Everything But Arms (EBA) initiative gives Bangladesh zero-tariff access to EU markets for virtually all product categories. The US GSP (Generalised System of Preferences) provides similar preferential access. Canada and Japan have equivalent LDC preference schemes.
For pharma manufacturers, the most immediate export opportunity is in Africa — specifically HIV/AIDS antiretrovirals, anti-malarial drugs, and anti-TB medicines where MSF, PEPFAR, and national health ministries purchase at scale. Indian generic manufacturers have dominated; Bangladeshi producers with WHO-GMP certification are now competitive alternatives, especially given the 2033 TRIPS window.
For light engineering products (bicycle parts, electrical fittings, fasteners), the EU and Japan are growing destination markets as global buyers diversify supply chains away from China. A Bogura-based light engineering MSME with ISO 9001 and export linkage through BIDA can access these markets directly.
Key Manufacturing Players in Bangladesh
|
Company / Entity
|
Sector
|
Note
|
|
BGMEA (Garment Association)
|
RMG / Policy
|
4,500+ member factories; export promotion and compliance standards
|
|
Square Pharmaceuticals
|
Pharmaceuticals
|
Bangladesh's largest pharma company; exports to 40+ countries
|
|
Beximco Pharmaceuticals
|
Pharmaceuticals / Textiles
|
Dual-listed pharma and textile company; Nasdaq-listed; exports globally
|
|
Ha-Meem Group
|
RMG Manufacturing
|
One of the largest denim and apparel exporters; works with H&M, Walmart
|
|
ACI Limited
|
FMCG / Agro
|
Consumer goods, pharma, and agribusiness; domestic market leader
|
|
BSRM (Bangladesh Steel)
|
Steel / Engineering
|
Leading long-steel producer; construction market anchor
|
|
Abdul Monem Ltd
|
Food & Beverages
|
Igloo Ice Cream, Coca-Cola franchise; domestic FMCG leader
|
|
Walton Group
|
Electronics / Engineering
|
Manufactures TVs, refrigerators, mobile phones; rapid domestic market share
|
Bangladesh's Growth Horizon Through 2035
Bangladesh faces a critical structural transition: LDC graduation is scheduled for 2026, after which the EBA trade preference will expire (with a 3-year transition grace period to 2029). This means Bangladesh's core garment sector will face EU tariffs of 9–12% after 2029 unless bilateral trade agreements are concluded. The industry is actively lobbying for an EU-Bangladesh FTA — negotiations began formally in 2022.
For entrepreneurs, this transition creates two opportunities: (1) sectors not affected by LDC graduation (pharmaceuticals' TRIPS window extends to 2033; light engineering is not preference-dependent; agro-processing is growing from domestic demand); and (2) the RMG supply chain — where domestic fabric and yarn producers serving Bangladesh's garment factories are insulated from export tariff changes because they are part of the domestic input chain, not the export chain.
By 2035, Bangladesh is projected to have graduated from LDC status, established preferential trade arrangements with the EU, and diversified its export base toward pharmaceuticals, electronics assembly (Walton effect), and light engineering. The domestic consumer market will have grown to one of South Asia's largest. A business entered today with proper positioning is in front of this growth curve.
Practitioner Q&A: 10 Questions Bangladesh Investors Actually Ask
Q1. Can Indian investors own 100% of a manufacturing business in Bangladesh?
Yes, in most manufacturing sectors. Bangladesh permits 100% foreign ownership in EPZs and most economic zones under BEZA. For businesses outside zones, a Bangladesh-incorporated company with 100% foreign shareholding is permitted in most manufacturing categories, subject to sectoral regulations. Joint ventures are not mandatory, though they are common for market access reasons.
Q2. What are the key differences between EPZ and BEZA economic zone structures?
EPZs (managed by BEPZA) are older, more established, and offer proven infrastructure and investor services — best for export-oriented manufacturers who want a tested zone environment. BEZA economic zones are newer, offer larger plot sizes, and include private economic zones where landowners also develop infrastructure. BEZA zones often offer longer tax holiday durations and more flexible land terms for larger projects.
Q3. How does the pharma TRIPS exemption work practically for a new manufacturer?
Bangladesh's TRIPS waiver (until 2033) means you can manufacture a molecule still under patent globally — e.g., a cancer drug or antiretroviral — without licensing from the originator company, solely for domestic supply or LDC-country export. You need DGDA approval for your facility and product registration. You cannot export to developed-country markets (US, EU, Japan) under this exemption — those markets still enforce patents.
Q4. Is political instability a significant business risk in Bangladesh right now?
Bangladesh underwent a government transition in August 2024 following student-led protests. The interim government has maintained macroeconomic policy continuity, honoured foreign investment commitments, and continued EPZ operations without disruption. Historical experience shows Bangladesh's garment and manufacturing economy has been resilient through multiple political transitions. Investors should use EPZ and BEZA structures — which have protected legal status — to mitigate political risk.
Q5. What is the labour cost situation in Bangladesh for manufacturing?
Bangladesh's minimum wage in the RMG sector was set at BDT 12,500 per month (~USD 113) following the December 2023 wage revision. For light engineering and food processing, wages are typically BDT 8,000–15,000 per month depending on skill level. This remains among the lowest manufacturing wage structures in Asia — though rising annually. Productivity per worker in specialised manufacturing is improving as education levels and training programmes expand.
Q6. How do I register a company in Bangladesh as a foreigner?
Register with BIDA (Bangladesh Investment Development Authority) for a project registration certificate. Then register your company with the Registrar of Joint Stock Companies and Firms (RJSC) — an online process available through the government e-portal. For EPZ establishment, apply directly to BEPZA. Total timeline for a standard registration: 3–5 weeks. BIDA's facilitation desk assists with sector-specific clearances.
Q7. What is the corporate tax rate in Bangladesh for manufacturing?
The standard corporate tax rate in Bangladesh is 27.5% for publicly traded companies and 30% for private companies. However, manufacturing units in EPZs enjoy 0% corporate tax for 10 years from commencement. New industry in industrial economic zones under BEZA may qualify for 5–10-year tax holidays depending on sector designation under the New Industrial Policy 2024.
Q8. Is Bangladesh's port infrastructure adequate for export manufacturing?
Chittagong Port handles over 90% of Bangladesh's containerised trade and is the 70th largest container port globally by throughput. It processed ~3.3 million TEUs in FY2024. Congestion is a known operational issue — particularly during peak garment shipment periods (September–November). Savvy exporters use freight booking well in advance, maintain relationships with multiple shipping lines, and plan production cycles to avoid peak port congestion windows.
Q9. What FMCG or food-related businesses have the lowest barrier to entry in Bangladesh?
Packaged rice (branded mill output), biscuits and bakery snacks, fruit juices, and drinking water have the lowest regulatory and capital barriers. A small biscuit manufacturing unit can start at BDT 50–80 lakh (~₹50–80 lakh equivalent) with BSTI (Bangladesh Standards and Testing Institution) product certification. Distribution through Dhaka's wholesale markets (Chawkbazar, Mirpur) is established and accessible for new brands.
Q10. What is the most important compliance step for a food or pharma manufacturer in Bangladesh?
For food: BSTI certification is mandatory for packaged food products, plus Trade Licence and VAT registration. For pharma: DGDA facility registration and drug registration (per product line) are mandatory before any commercial production or export. The DGDA facility inspection process for WHO-GMP certification typically takes 6–12 months from application to approval for a new facility — plan this timeline into your project schedule.
The Bottom Line
Bangladesh is South Asia's most export-proven manufacturing destination — and is now actively expanding beyond its garment base into pharmaceuticals, light engineering, and processed foods. The LDC trade preferences, pharma TRIPS window until 2033, low labour costs, and 100 active economic zones make it a high-potential destination for investors who want a Southeast Asian production platform without Thailand or Vietnam's higher entry costs.
The most valuable government support available right now: EPZ tax holidays (10 years at 0% corporate tax), BIDA single-window facilitation, the New Industrial Policy 2024's fast-track registration, and the Startup Accelerator Fund for digital and technology ventures.
Your first step: Contact BIDA or BEPZA to identify the right zone structure for your product. Submit a project investment proposal online — BIDA's digital portal has reduced registration to a single-form submission. For pharma, contact DGDA simultaneously for facility inspection pre-registration. Begin planning your supply chain and raw material sourcing in parallel.
References
1. Export Promotion Bureau (EPB), Bangladesh — Annual Export Statistics FY2024.
2. Bangladesh Export Processing Zones Authority (BEPZA) — Annual Report 2023–24.
3. World Bank — Bangladesh Country Overview and GDP Per Capita Data, 2024.
4. Bangladesh Investment Development Authority (BIDA) — FDI Registration and Investment Policy Framework, FY2024.
5. Directorate General of Drug Administration (DGDA), Bangladesh — Pharmaceutical Manufacturing and Export Data, FY2024.
6. International Monetary Fund (IMF) — Bangladesh Article IV Consultation Report, 2024; GDP forecast.
